“…Indeed, the fact that MFB produce a factor that promotes vasculogenesis [15], hematopoiesis [23], and progenitor cell survival [14,41,42] calls into question the wisdom of therapeutic attempts to induce apoptosis in MFB as a strategy for reducing liver fibrosis [48][49][50][51][52]. In other tissues, wound healing is impaired when Shh is inhibited, and accelerates when supplemental Shh is administered [17,21,41,[53][54][55][56].…”